Drugs / Prepopik
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02124447 Comparator | Jun → Aug 2014 | — | Medical College of Wisconsin | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prepopik | “3. Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid (P+MC): Brand name Prepopik” NCT02124447 ↗ |
| Known as | P+MC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02124447 ↗ |